Apomab, a fully human agonistic DR5 monoclonal antibody inhibits tumour growth and osteolysis in murine models of breast cancer development and progression Meeting Abstract
| Authors: | Zinonos, I.; Labrinidis, A.; Liapis, V.; Hay, S.; Lee, M.; Ponomarev, V.; Diamond, P.; Zannettino, A. C. W.; Findlay, D. M.; Evdokiou, A. |
| Abstract Title: | Apomab, a fully human agonistic DR5 monoclonal antibody inhibits tumour growth and osteolysis in murine models of breast cancer development and progression |
| Meeting Title: | 2nd Joint Meeting of the International Bone & Mineral Society and the Australian & New Zealand Bone & Mineral Society |
| Journal Title: | Bone |
| Volume: | 44 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2009 Mar 21-25 |
| Meeting Location: | Sydney, Australia |
| ISSN: | 8756-3282 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2009-05-01 |
| Start Page: | 104 |
| Language: | English |
| ACCESSION: | ISI:000265436200096 |
| DOI: | 10.1016/j.bone.2009.01.463 |
| PROVIDER: | wos |
| PUBMED: | 19324325 |
| Notes: | --- - Meeting Abstract: 104 - Suppl. 1 - "Source: Wos" |
